BAY1830839: First in Man, Single Dose Escalation, Safety & Tolerability and Pharmacokinetics

Clinical trial NCT03540615 · COMPLETED

Trial details

NCT number: NCT03540615
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2018-06-28
Primary completion: 2019-02-05
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.